Integrating Science And Computational Talent

Compute specialists and traditional scientists speak different languages, but to effectively deploy and benefit from computational biology technologies, they need to gel. During our Bioprocess Online Live event, How Computational Biology Speeds Drug Discovery, Development, Tina Larson, President and COO at Recursion, and Andrew Satz, CEO and Co-Founder at EVQLV, shared best practices on how to get the holders of seemingly disparate intellectual property to collaborate effectively.